Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05367440
Title Study of AZD5305 When Given in Combination With New Hormonal Agents in Patients With Metastatic Prostate Cancer (PETRANHA)
Recruitment Recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors AstraZeneca

prostate cancer


AZD5305 + Darolutamide

Abiraterone + AZD5305

AZD5305 + Enzalutamide

Age Groups: adult | senior
Covered Countries

No variant requirements are available.